Pamela Silver

Director

Pamela Silver received her BS in Chemistry and PhD in Biochemistry from the University of California where she was an NIH Pre-doctoral Fellow. She was a Postdoctoral Fellow at Harvard University in the Dept of Biochemistry and Molecular Biology where she was a Fellow of the American Cancer Society and The Medical Foundation. Subsequently, Pam was an Assistant Professor in the Dept of Molecular Biology at Princeton University where she was an Established Investigator of the American Heart Association, a Research Scholar of the March of Dimes and was awarded an NSF Presidential Young Investigator Award. Pam moved to the Dana Farber Cancer Institute where she was a Professor in the Dept of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. She was named a Claudia Adams Barr Investigator and awarded the Mentoring Award for the PhD Program in Biological and Biomedical Sciences at Harvard Medical School.

In 2004, Pam became one of the founding members of the Department of Systems Biology at Harvard Medical School and the first Director of the Harvard University PhD Program in Systems Biology. In 2009, she became one of the first members of the Harvard University Wyss Institute for Biologically Inspired Engineering. Her work was recognized by an Innovation Award at BIO2007 and has been funded by grants from the NIH, DARPA, DOD, DOE, NSF, Novartis, Merck and The Keck Foundation. Her work has been recognized by an Established Investigator of the American Heart Association, a Research Scholar of the March of Dimes, an NSF Presidential Young Investigator Award, Claudia Adams Barr Investigator, an NIH MERIT award, the Philosophical Society Lecture, a Fellow of the Radcliffe Institute, and election to the American Academy of Arts and Sciences. She is among the top global influencers in Synthetic Biology and her work was named one of the top 10 breakthroughs by the World Economic Forum. She serves on numerous public and private advisory boards including the board of the Internationally Genetics Engineering Machines (iGEM) Competition, and she is the co-founder of several biotech companies. She is a voting member of the National Science Advisory Board for Biosecurity.